Vaccine targets malignant brain cancer antigens, significantly lengthens survival

Wednesday, August 15, 2012 - 09:00 in Health & Medicine

An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor, researchers report.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net